John T. Curnutte

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.

B. Ames, F. Chisari, C. Wehr, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.

W. Nauseef, R. Clark, D. W. Pearson, 1989, The New England journal of medicine.

Chronic granulomatous disease

D. Roos, John T. Curnutte, Dirk Roos, 1999 .

Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.

D. Speert, J. Curnutte, R. Woodman, 1994, The Journal of infectious diseases.

Defect in pyridine nucleotide dependent superoxide production by a particulate fraction from the cranulocytes of patients with chronic granulomatous disease.

B. Babior, R. S. Kipnes, J. Curnutte, 1975, The New England journal of medicine.

Chronic granulomatous disease.

B. Babior, J. Curnutte, R. Woodman, 1987, Advances in human genetics.

Evidence that de novo protein synthesis participates in a time-dependent augmentation of the chemotactic peptide-induced respiratory burst in neutrophils. Effects of recombinant human colony stimulating factors and dihydrocytochalasin B.

B. Babior, J. Curnutte, R. Woodman, 1988, Free radical biology & medicine.

Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.

S. Shurin, R. Berkow, J. Curnutte, 1988, The Journal of clinical investigation.

Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.

K. Starko, J. Curnutte, D. Roberts, 1995, Blood cells, molecules & diseases.